financetom
Business
financetom
/
Business
/
AppLovin Insider Sold Shares Worth $6,081,153, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AppLovin Insider Sold Shares Worth $6,081,153, According to a Recent SEC Filing
Aug 25, 2025 12:51 AM

03:24 AM EDT, 08/25/2025 (MT Newswires) -- Arash Adam Foroughi, 10% Owner, Director, Chief Executive Officer & Chairperson, on August 20, 2025, sold 15,042 shares in AppLovin ( APP ) for $6,081,153. Following the Form 4 filing with the SEC, Foroughi has control over a total of 8,913 Class A common shares of the company, with 8,913 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1751008/000156218025005963/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airlines Must Pay Automatic Refunds for Canceled Flights Under New US Rule
Airlines Must Pay Automatic Refunds for Canceled Flights Under New US Rule
Apr 24, 2024
09:02 AM EDT, 04/24/2024 (MT Newswires) -- Airlines will have to provide automatic refunds to customers if their flights are canceled or altered significantly under a new rule issued Wednesday by the US Department of Transportation. In addition to refunds for canceled or significantly altered flights, the new rule requires refunds for significantly delayed baggage returns and for extra services...
BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting
BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting
Apr 24, 2024
09:00 AM EDT, 04/24/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) , which is developing immunotherapies to treat cancer, said it will make a presentation on the clinical data of the randomized Phase 2 study evaluating Bria-IMT in patients with advanced metastatic breast cancer at the 2024 American Society of Clinical Oncology annual meeting in Chicago from May 31...
Stifel Financial's Q1 Non-GAAP Earnings, Revenue Rise
Stifel Financial's Q1 Non-GAAP Earnings, Revenue Rise
Apr 24, 2024
09:00 AM EDT, 04/24/2024 (MT Newswires) -- Stifel Financial ( SF ) reported Q1 non-GAAP earnings Wednesday of $1.49 per diluted share, up from $1.40 a year earlier. Analysts polled by Capital IQ expected $1.43. Revenue for the quarter ended March 31 was $1.16 billion, up from $1.11 billion a year earlier. Analysts surveyed by Capital IQ expected $1.14 billion....
Interpublic Group Q1 Adjusted Earnings, Revenue Decrease
Interpublic Group Q1 Adjusted Earnings, Revenue Decrease
Apr 24, 2024
09:02 AM EDT, 04/24/2024 (MT Newswires) -- Interpublic Group (IPG) reported Q1 adjusted earnings Wednesday of $0.36 per diluted share, down from $0.38 a year earlier. Analysts polled by Capital IQ expected $0.35. Revenue from the quarter ended March 31 was $2.5 billion, down from $2.52 billion a year earlier. Excluding billable expenses, the company reported revenue of $2.18 billion,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved